/**/ RNS Number : 1961U IQ-AI Limited 22 January 2025   IQ-AI Ltd (“IQ-AI” or the “Company”)   Operations Update   IQ-AI is pleased to announce an operations update. In this update, we focus on the relevance of artificial intelligence (“AI”) to our business, describe ongoing product development utilising AI in 2025, and provide an…

Read more . . .

/**/ RNS Number : 8964S IQ-AI Limited 10 January 2025   IQ-AI Ltd ​ (“IQ-AI” or the “Company”)   Imaging Biometrics and Prism Clinical Imaging Secure First Installation   The combined technologies will enhance neurosurgical planning and treatment strategies      Imaging Biometrics (IB), a wholly owned subsidiary of IQ-AI Ltd (LSE: IQAI), is pleased…

Read more . . .

/**/ RNS Number : 8473M IQ-AI Limited 20 November 2024   November 20, 2024 IQ-AI Ltd (“IQ-AI” or the “Company”) Imaging Biometrics Expands Distribution   Imaging Biometrics (IB), Elm Grove, WI, a wholly owned subsidiary of IQ-AI Ltd (LSE: IQAI) has renewed its distribution agreement with GE HealthCare. This agreement aims to expand the distribution…

Read more . . .

/**/ RNS Number : 8206M IQ-AI Limited 19 November 2024   IQ-AI Ltd (“IQ-AI” or the “Company”)   Board Changes   IQ-AI Appoints Renowned Brain Tumor Champion to Board of Directors     IQ-AI Ltd (LSE: IQAI) is pleased to announce the appointment of Dr. Al Musella, MD, as a Non-Execuitve Director. Dr. Musella brings…

Read more . . .

/**/ RNS Number : 8681K IQ-AI Limited 05 November 2024   November 5, 2024 IQ-AI Ltd (“IQ-AI” or the “Company”)   New Patent Application, Trading Update and Commencement of discussions with potential phase 2 partners   IQ-AI (LSE: IQAI) Imaging Biometrics (“IB”) has filed a provisional patent application with the United States Patent and Trademark…

Read more . . .